These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Low-dose supplementation with lycopene or beta-carotene does not enhance cell-mediated immunity in healthy free-living elderly humans.
    Author: Corridan BM, O'Donoghue M, Hughes DA, Morrissey PA.
    Journal: Eur J Clin Nutr; 2001 Aug; 55(8):627-35. PubMed ID: 11477460.
    Abstract:
    OBJECTIVE: To assess the effects of supplementation with the carotenoids, beta-carotene or lycopene, at levels achievable within a diet rich in fruit and vegetables, on immune function in a group of free-living healthy elderly. DESIGN: A double-blind randomized placebo-controlled trial. T cell subsets and the expression of functionally associated cell surface molecules, quantified by flow cytometry, and lectin-stimulated lymphocyte proliferation, were compared before and following the treatment period. SUBJECTS: Fifty-eight subjects aged over 65 y were recruited; 52 were included in the final analysis. INTERVENTIONS: Participants received one placebo, one lycopene (13.3 mg) or one beta-carotene (8.2 mg) capsule daily for 12 weeks. RESULTS: No significant differences were observed in any of the parameters examined following either lycopene or beta-carotene supplementation. CONCLUSIONS: In well-nourished, free-living, healthy elderly individuals, supplementation with relatively low levels of beta-carotene or lycopene is not associated with either a beneficial or detrimental effects on several aspects of cell-mediated immunity.
    [Abstract] [Full Text] [Related] [New Search]